Li Dingfeng Professor, Chief Physician
Renowned Expert at the Cancer Hospital of the Chinese Academy of Medical Sciences
Chief Physician at the Affiliated Hospital of the Academy of Military Medical Sciences/Professor
Standing Director of the Expert Committee on Classical Formula Treatment of Tumors, World Federation of Chinese Medicine Societies
Standing Member of the Strategic Alliance for Technological Innovation in Minimally Invasive Tumor Treatment of China
Standing Member of the National Expert Committee on Integrated Chinese and Western Medicine Tumor Prevention and Treatment
Member of the Bone Tumor Group, Beijing Orthopaedic Society
Expert Profile: 1983 Graduated from the Medical Department of Capital Medical University in 1991, was sent to Japan on a government scholarship to study tumor treatment.Previously served at the Cancer Hospital of the Chinese Academy of Medical Sciences and the Affiliated Hospital of the Academy of Military Medical Sciences(Beijing307Hospital.)Chief physician, long engaged in clinical and molecular biology research on bone and soft tissue tumors, with extensive clinical and basic research experience in the field of bone and soft tissue tumors. Practicing for40 years, he has obtained ... national utility model patents11patents, published ... papers domestically and internationally, national and provincial/ministerial-level research projects, published 50received ... third-class medical achievement1awards, the Academy of Military Medical Sciences Outstanding Paper Award2times, and the Academy of Military Medical Sciences Annual Individual Commendation4times. Academic committee member of the China Tumor Minimally Invasive Treatment Technology Innovation Strategic Alliance,Standing Member of the National Expert Committee on Integrated Chinese and Western Medicine Tumor Prevention and Treatment，Member of the Bone Tumor Group, Beijing Orthopaedic Society, committee member of the Bone and Soft Tissue Tumor Professional Committee of the Beijing Anti-Cancer Association,2008... year committee member of the PLA Bone Tumor Branch,Standing Director of the Expert Committee on Classical Formula Treatment of Tumors, World Federation of Chinese Medicine Societies。
Professional Expertise: engaged in clinical oncology work for40 yearsclinical research. His patentstechnology of"subcutaneously implanted arterial-directed chemotherapy"has shown remarkable therapeutic efficacy for soft tissue sarcoma, osteosarcoma, and other conditions. He has unique treatment experience formalignant tumorbone metastases.
1, limb-salvage surgery for bone and soft tissue tumors;
2, spinal and sacral tumor surgery;
3, bone metastases((lung cancer, breast cancer, thyroid cancer, renal cancer, prostate cancer, liver cancer, gastric cancer, colorectal cancer, brain tumors));
4, primary bone tumors((bone tumors, osteosarcoma,ㄤEwing sarcoma, osteoblastoma, chondrosarcoma, liposarcoma, and other bone and soft tissue sarcomas));
5, subcutaneously implanted interventional chemotherapy for tumors. He has successively obtained patents for a subcutaneously implanted arterial chemotherapy device, an extendable adjustable artificial joint prosthesis, and a radioactive seed composite artificial joint prosthesis, among others. patents。